Background illustration for clinical trials search

Paid Clinical Trials Salem

Discover 951 paid clinical trials in Salem, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Clinical Study of YL205 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Portland OR, Seattle WA, Las Vegas NV, Albuquerque NM,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06459973

Phase1, Phase2, Recruiting

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

for
Small Cell Lung Cancer Metastatic or Locally Advanced,
Location: Portland OR, Seattle WA, Los Angeles CA, Aurora CO,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT07080242

Phase1, Recruiting

A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread

for
Prostate Cancer
Location: Portland OR, Hackensack NJ
Sponsor: Regeneron Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT07543055

Phase1, Recruiting

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

for
Epithelial Ovarian Cancer, Ovarian Cancer,
Location: Portland OR, Spokane WA, Sioux Falls SD, Minneapolis MN,
Sponsor: Imunon

Sex: Female

Age: 18+

Code: NCT06915025

Phase3, Recruiting

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Portland OR, Seattle WA, Los Angeles CA, La Jolla CA,
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT06787612

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies

for
Advanced Solid Tumors
Location: Portland OR
Sponsor: Providence Health & Services

Sex: All

Age: 18+

Code: NCT06719362

Phase1, Recruiting

A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)

for
Small Cell Lung Cancer Extensive Stage
Location: Portland OR, Santa Rosa CA, Aurora CO, Sioux Falls SD,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07227597

Phase1, Phase2, Recruiting

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

for
Non-small Cell Lung Cancer
Location: Portland OR, Reno NV, San Francisco CA, Fresno CA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07195695

Phase3, Recruiting

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

for
Renal Cell Carcinoma
Location: Portland OR, Seattle WA, Los Angeles CA, La Jolla CA,
Sponsor: HiberCell, Inc.

Sex: All

Age: 18+

Code: NCT06234605

Phase1, Recruiting

Study of AVZO-021 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor, HR+/HER2- Breast Cancer,
Location: Portland OR, Oklahoma City OK, Dallas TX, Cleveland OH,
Sponsor: Avenzo Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05867251

Phase1, Phase2, Recruiting

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

for
Advanced Breast Cancer
Location: Portland OR, San Francisco CA, Palo Alto CA,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06638307

Phase1, Recruiting

A Phase 1/1b Study of IAM1363 in HER2 Cancers

for
HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer,
Location: Portland OR, Seattle WA, West Valley City UT,
Sponsor: Iambic Therapeutics, Inc

Sex: All

Age: 18+

Code: NCT06253871

Phase1, Recruiting

Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

for
Kidney Cancer
Location: Portland OR, Los Angeles CA, Maywood IL,
Sponsor: Jonsson Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT00301990

Phase2, Recruiting

A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

for
Cervical Cancer
Location: Portland OR, Reno NV, Palo Alto CA, Los Angeles CA,
Sponsor: GOG Foundation

Sex: Female

Age: 18+

Code: NCT04831580

Recruiting

PREVENT ALL ALS Study

for
Amyotrophic Lateral Sclerosis
Location: Portland OR, Seattle WA, Boise ID, San Francisco CA,
Sponsor: St. Joseph's Hospital and Medical Center, Phoenix

Sex: All

Age: 18+

Code: NCT06581861

Recruiting

Evaluation of a Novel mHealth Intervention for People Who Are Ambivalent About Quitting Smoking

for
Smoking Behaviors
Location: Portland OR
Sponsor: Kaiser Permanente

Sex: All

Age: 18+

Code: NCT07459621

Recruiting

A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older

for
Clostridoides Difficile Associated Disease
Location: Portland OR, Seattle WA, Everett WA, Reno NV,
Sponsor: Pfizer

Sex: All

Age: 65+

Code: NCT07282665

Phase3, Recruiting

Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start

for
Contraception
Location: Portland OR, Seattle WA, San Jose CA, Salt Lake City UT,
Sponsor: University of Utah

Sex: Female

Age: 16 - 35

Code: NCT05444582

Recruiting

A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

for
Solid Tumors, Neoplasms
Location: Portland OR, Seattle WA, Santa Rosa CA,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06431594

Phase1, Recruiting

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

for
Neovascular Age-Related Macular Degeneration (nAMD)
Location: Portland OR, Eugene OR, Silverdale WA, Reno NV,
Sponsor: 4D Molecular Therapeutics

Sex: All

Age: 50+

Code: NCT07064759

Phase3, Recruiting